Results 121 to 130 of about 59,666 (243)

Breast Milk Oligosaccharides Contain Immunomodulatory Glucuronic Acid and LacdiNAc. [PDF]

open access: yesMol Cell Proteomics, 2023
Jin C   +4 more
europepmc   +1 more source

Evaluation of Different Detection and Identification Methods of Intact Tetrahydro‐Methyltestosterone Sulfate Metabolites in Doping Control

open access: yesDrug Testing and Analysis, Volume 18, Issue 5, Page 678-689, May 2026.
The micro‐scale synthesis of the six out of eight possible tetrahydro‐methyltestosterone sulfate metabolites was performed, and the synthesized materials were used as analytical standards. The analysis of post‐administration sample extracts from methyltestosterone excretion studies against these standards provides further experimental proof for their ...
Yiannis S. Angelis   +3 more
wiley   +1 more source

Extraction, Structural Characterization and Anti‐Inflammatory Activity of Polysaccharides From Conioselinum vaginatum

open access: yesFood Science &Nutrition, Volume 14, Issue 5, May 2026.
This study employed an ultrasonic‐assisted extraction (UAE) method combined with column chromatography purification to obtain two homogeneous polysaccharides (CVP‐I and CVP‐II) from Conioselinum vaginatum, which exhibited distinct physicochemical properties and structural characteristics, and exerted anti‐inflammatory effects by inhibiting the ...
Conghui Ren   +6 more
wiley   +1 more source

Unexpected Diastereomer Formation and Interconversions in Cyclohexane-1,2-diacetal Derivatization of a Glucuronic Acid Thioglycoside. [PDF]

open access: yesOrg Lett, 2023
Alharthi FA   +5 more
europepmc   +1 more source

A spectrophotometric study of the behavior of carbohydrates in seventy-nine per cent sulfuric acid [PDF]

open access: yes, 1949
The spectral characteristics of solutions of eighteen representative monosaccharides in 79 per cent sulfuric acid have been determined for solutions maintained for 2 hours at 25° and 15 minutes at 100°.
Ikawa, Miyoshi, Niemann, Carl
core  

Liver Transplantation Outcomes in Crigler‐Najjar Syndrome in Iran: A Single‐Center Retrospective Cohort Study Over 20 Years

open access: yesHealth Science Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background and Aims Crigler‐Najjar Syndrome (CNS) is a rare autosomal recessive disorder caused by uridine diphosphate glucuronosyltransferase (UGT1A1) deficiency, leading to unconjugated hyperbilirubinemia. Without treatment, patients are at high risk of kernicterus and irreversible neurological damage.
Sajad Teimoury   +6 more
wiley   +1 more source

Functional metabolites and inhibitory efficacy of kombucha beverage on pathogenic bacteria, free radicals and inflammation

open access: yesScientific Reports
Kombucha tea is a fermented tea that produced by acetic acid bacteria and yeast. In this study, the kombucha tea from white, green and black tea was studied for its microbial composition, chemical profile, and biological activities during 15-day ...
Nitsanat Cheepchirasuk   +5 more
doaj   +1 more source

STUDIES ON GLUCURONIC ACID BIOSYNTHESIS

open access: yesNihon Naika Gakkai Zasshi, 1955
1) URINARY EXCRETION OF THE PREFORMED GLUCURONIC ACID, AND THE INFLUENCE OF GLUCURONIC ACID UPON THE URINARY EXCRETION OF MEN-THYLGLUCURONIDE IN RABBITS.The preformed glucuronic acid injected to rabbit was excreted into the urine rapidly, and 75 to 90% of the injected dose was excreted within six hours.
openaire   +2 more sources

In Vitro and Clinical Evaluation of Potential Interactions of Bemnifosbuvir with Drug‐Metabolizing Enzymes

open access: yesThe Journal of Clinical Pharmacology, Volume 66, Issue 5, May 2026.
Abstract Bemnifosbuvir is a novel oral guanosine nucleotide prodrug with potent pan‐genotypic inhibitory activity against hepatitis C virus. In vitro studies assessing the inhibition or induction potential of bemnifosbuvir on the CYP450 and UGT1A1 enzymes demonstrated that bemnifosbuvir is a weak inducer and a reversible and time‐dependent inhibitor of
Xiao‐Jian Zhou   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy